A Study to Evaluate the Effectiveness of STELARA ™ (USTEKINUMAB) in the Treatment of Scalp Psoriasis
Status:
Unknown status
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
This is a single site, randomized, placebo-controlled, cross-over trial of sub-cutaneous
injections of placebo and Stelara™ (ustekinumab) in subjects with scalp psoriasis.The purpose
of the study is to assess the effectiveness of Stelara™ (ustekinumab)in the treatment of
scalp psoriasis by determining the proportion of subjects who clear or almost clear in scalp
specific physician assessments. The study will include approximately 30 subjects.